NCT06091904 Effects of Sufentanil on the Intraoperative Hemodynamics
| NCT ID | NCT06091904 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Hospital |
| Condition | Intraoperative Hypotension |
| Study Type | INTERVENTIONAL |
| Enrollment | 92 participants |
| Start Date | 2023-11-24 |
| Primary Completion | 2025-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 92 participants in total. It began in 2023-11-24 with a primary completion date of 2025-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a randomized, controlled trial. A total of 92 patients will be randomized to receive sufentanil or remifentanil during extracranial-intracranial bypass surgery.
Eligibility Criteria
Inclusion Criteria: * Patients who undergo elective extracranial-intracranial bypass surgery * American Society of Anesthesiologists grade 1,2,3 * Age \> 18 years old Exclusion Criteria: * Refuse to participate to the study * American Society of Anesthesiologists grade 4 * Body Mass Index \< 18.5 kg/m2 or \> 35 kg/m2 * Allergic history of opioid * pregnant * MAO Inhibitor user * Severe respiratory insufficiency
Contact & Investigator
Chang-Hoon Koo
PRINCIPAL INVESTIGATOR
Seoul National University Bundang Hospital
Frequently Asked Questions
Who can join the NCT06091904 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Intraoperative Hypotension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06091904 currently recruiting?
Yes, NCT06091904 is actively recruiting participants. Contact the research team at vollock9@gmail.com for enrollment information.
Where is the NCT06091904 trial being conducted?
This trial is being conducted at Seongnam-si, South Korea.
Who is sponsoring the NCT06091904 clinical trial?
NCT06091904 is sponsored by Seoul National University Hospital. The principal investigator is Chang-Hoon Koo at Seoul National University Bundang Hospital. The trial plans to enroll 92 participants.